USV Private Limited

Glenmark Pharmaceuticals has launched the first biosmilar to Novo Nordisk ’s glucagon‐like peptide 1 (GLP-1) receptor agonist Victoza (liraglutide) in India, kicking off 2024 with a high-profile deb

Glenmark Pharmaceuticals Limited has launched the first biosmilar to Novo Nordisk ’s glucagon‐like peptide 1 (GLP-1) receptor agonist Victoza (liraglutide) in India, kicking off 2024 with a high-pro

Novo Nordisk A/S ’s semaglutide and Eli Lilly and Company ’s tirzepatide, now proven to offer the perfect combination of treating type 2 diabetes while also reducing obesity, have not just found admi

Novartis Pharma AG has handed over manufacturing and marketing rights for Galvus, its vildagliptin mother brand and combinations, in India to Cipla Limited , as part of what appears to be a wider p